ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 73.75 +1.51 (2.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.24 | 52 Week High | $70.92 | |||
| Open | $72.50 | 52 Week Low | $26.80 | |||
| Day High | $74.15 | P/E | N/A | |||
| Day Low | $71.85 | EPS | $-0.96 | |||
| Volume | 454,416 | |||||
